Major histocompatibility complex, class II, DP beta 1 chain (HLA-DPB1)

Major histocompatibility complex, class II, DP beta 1 chain (HLA-DPB1) is a transmembrane glycoprotein that forms the beta chain component of the HLA-DP heterodimer, a member of the MHC class II family in humans[1][3][4]. HLA-DPB1, together with its alpha partner (HLA-DPA1), is primarily expressed on professional antigen-presenting cells (APCs) like B lymphocytes, dendritic cells, and macrophages[1][3]. The primary function of HLA-DPB1 is to bind peptides derived from extracellular proteins and present them on the cell surface for recognition by CD4+ T cells, thus playing a central role in the adaptive immune response and tolerance[1][3][4]. The HLA-DPB1 gene is highly polymorphic, with different alleles contributing to individual variability in immune responsiveness and susceptibility to disease[2]. HLA-DPB1 mismatches between donor and recipient are a major cause of alloimmune responses in transplantation, affecting risk of graft-versus-host disease in stem cell transplantation and organ transplant rejection[2]. Certain HLA-DPB1 polymorphisms are also associated with susceptibility to diseases such as berylliosis[1]. HLA-DPB1 is not itself directly targeted by therapeutic drugs, but its presence and variants are important biomarkers in immunogenetics and transplantation medicine. **Supporting context and notes:** - HLA-DPB1 is best classified as an MHC class II antigen-presenting molecule, not a typical “receptor” or enzyme[1][3][4]. - While not a direct molecular target for approved drugs, it is a critical target in transplantation immunology because mismatches elicit immune responses, and its genotyping/phenotyping is routinely used in clinical settings for patient selection and risk assessment[2][1]. - There are no small molecules or biologics that directly modulate HLA-DPB1 function in a selective manner; interventions are indirect (e.g., immunosuppressive regimens). - Safety concerns center on its alloantigenicity and risk of adverse immune responses following transplantation (allograft rejection or GVHD)[2].

Other names

HLA class II histocompatibility antigen, DP beta 1 chainHLA-DP1BHLA-DPMHC class II antigen DPB1HLA-DPBHLA-DP histocompatibility type, beta-1 subunitMHC class II HLA-DP-beta-1HLA class II histocompatibility antigen, DP(W4) beta chainDPB1DPB1_HUMAN